about
Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitorsA V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer.Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5{alpha} proteins.Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells.Adaptation of HIV-1 to cells expressing rhesus monkey TRIM5αShort communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workersA broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry.Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individualsSlaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cellsCD4 mimetics sensitize HIV-1-infected cells to ADCC.Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses.Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected IndividualsHIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.HIV-1 Adapts To Replicate in Cells Expressing Common Marmoset APOBEC3G and BST2Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityThe highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions.Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimerTransitions to and from the CD4-bound conformation are modulated by a single-residue change in the human immunodeficiency virus type 1 gp120 inner domainResistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.Molecular basis for epitope recognition by non-neutralizing anti-gp41 antibody F240A Highly Conserved Residue in HIV-1 Nef Alpha Helix 2 Modulates Protein Expression.First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity.Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses.Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.Effect of HIV-1 Env on SERINC5 AntagonismLineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency VirusNovel Acylguanidine-Based Inhibitor of HIV-1.NKG2D Acts as a Co-receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity.Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay.The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.Unlocking HIV-1 Env: implications for antibody attack.Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique.Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.
P50
Q26782237-A98D5DD8-D5EC-410D-905D-F6119A734536Q28477736-59A8B64F-8E2A-4752-82BA-41DF7D51F96FQ33725702-A3364790-DAA4-4C25-8F29-4B7117D22205Q33769288-01706F55-9ADF-4730-9DC9-8BE54E837861Q34020606-F19C09E7-9E1D-4F96-AA70-4490066BF466Q34288181-4EFC8823-ED27-42F5-AFE9-DEBC81C85981Q34399515-14159C7F-4747-4E5C-8AF7-9D9868BCBC51Q34509949-E5D6B2EA-E582-4A76-8259-0D594B1A739EQ34742795-D92579B0-7CE2-4074-9841-FE926ADF7357Q34992575-C619BF2E-F4FA-427B-A594-DA5E6EA80C0DQ34992670-EC21A518-FAF6-4108-A528-CC9EDAAA4271Q35644696-1215BC51-144A-4E43-A784-DEFFE310EFA7Q36053810-1405ACDA-8587-4E12-A867-ABEAB408FBA1Q36108518-6D4AAF43-DAC8-4F91-BA3E-174E0988D319Q36323975-66167D76-0E24-4EFC-A87F-7B69FC7837E2Q36434202-8B2461E4-52B4-49C5-B47C-6A1CD5BD670DQ36538762-F109FB1B-6D4E-407D-9FC0-332F58141B57Q36607016-CD7F9655-BDC0-4765-90C2-D42B208C3DF4Q36978951-0F609A19-6021-4B85-BBEE-191905883645Q37049334-D4A539C7-FBCB-4208-B711-0CC1F84ED111Q37333789-84A0EE8D-8C69-495D-B46A-056B968D1633Q37359047-E0131EB4-E16C-4CE9-8DA5-1262494E2557Q37363561-4EA47F74-1F56-49B1-921D-67F95060C975Q37402557-2ECE7397-6B1B-48B8-B786-E9495496C1E2Q37405282-268A0057-589B-4D25-A47D-C81F54DD0925Q37449883-3B9618C2-2FC4-41DC-B9CB-ECEF4492543CQ37644079-C365279F-DEFF-4EAE-B0AE-B30A02A0C4D4Q38574538-28B767C3-6869-4905-8AE6-7060144D1827Q38725490-51BAD66F-F359-46F8-8B0E-75722E8F3B37Q38727228-C78C0FB3-A520-4BC5-9A3A-699C63598667Q38736210-225024D6-20B5-45E0-A1AA-A5E2D00C2462Q38752518-9B7C3266-C442-42F5-8047-2067077F47A1Q38754011-97089E4E-1B6A-4445-A284-155AB6B56F1FQ38761136-6C55D22C-36B4-4743-9244-E71A2204D215Q38812544-38A7174B-F774-4A3A-B01F-32B1E0E8AF9AQ38950236-0290A6B2-493B-4007-8754-30F57F9D43BCQ39013830-331F74A0-8CF9-419D-A648-8F9781C29A40Q40053224-E1CF7B7F-909A-47EA-877B-8A7C5BBF811CQ40054042-A6A8B61C-2FCF-425D-9F81-22008E5546C7Q40132008-87A9D48E-FB1C-4E79-8582-9E947A74A93E
P50
description
researcher ORCID ID = 0000-0002-4992-5288
@en
wetenschapper
@nl
name
Andrés Finzi
@ast
Andrés Finzi
@en
Andrés Finzi
@es
Andrés Finzi
@nl
type
label
Andrés Finzi
@ast
Andrés Finzi
@en
Andrés Finzi
@es
Andrés Finzi
@nl
prefLabel
Andrés Finzi
@ast
Andrés Finzi
@en
Andrés Finzi
@es
Andrés Finzi
@nl
P101
P21
P31
P496
0000-0002-4992-5288